Malin will not need to raise funds, says chief executive

Adrian Howd, Malin chief executive, Neil McLoughlin, chief operating officer and company secretary, and Ian Curley, chairman, at the company’s AGM. Pic: Barry Cronin

Biotech and drug investment fund Malin has said it will not need to raise fresh cash from shareholders and it has no plans to expand its portfolio of companies as it looks to turnaround its fortunes.

Malin’s chief executive Adrian Howd said the company would focus its attention on a slimmed down portfolio of investments and would not seek to invest in any further businesses.

“What we’ve said is we have begun a ...